Clinical Trial Update: Rifaximin and Propranolol Combination Therapy Versus Propranolol Monotherapy in Cirrhotic Patients [Phase 2, Phase 3]

View source ↗

Summary

This document reports a Phase 2/3 clinical trial evaluating rifaximin in combination with propranolol versus propranolol alone in patients with cirrhosis and po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Portal Hypertension

Drugs mentioned

• Propranolol (propranolol)
• XIFAXAN (rifaximin)

Snippet

Sponsor: Yonsei University | Conditions: Liver Cirrhosis, Portal Hypertension | Phase 2, Phase 3 | Status: UNKNOWN